Aparna Higgins, senior vice president of Private Market Innovations and Center for Policy and Research at America’s Health Insurance Plans (AHIP), explained that CMS and AHIP’s recent release of set core quality measures was an effort to help harmonize the varying types of measures that already exist as well as to focus in on quality improvement efforts.
Aparna Higgins, senior vice president of Private Market Innovations and Center for Policy and Research at America’s Health Insurance Plans (AHIP), explained that CMS and AHIP’s recent release of core quality measures was an effort to help harmonize the varying types of measures that already exist as well as to focus in on quality improvement efforts.
Transcript (slightly modified)
CMS and AHIP recently released sets of core quality measures. What is the importance of this effort?
There’s a lot of variability in the measures that are being used in public as well as private programs and variability in measures across these programs. And, we had done some work to look at that, had published a paper, sort of looking at that variability a little bit more systematically and I think it makes it difficult for clinicians to focus their quality improvement efforts when they’re being ask to report and being measured on lots of different measures.
And so I think what this helps do is to help focus quality improvement efforts, really helps focus efforts on measures that are evidence-based, that are high value and help drive quality improvement and ultimately, patient outcomes.
How difficult can it be for providers and hospitals to provide high-quality care when there is not a core set of measures to guide them?
When there’s a lot of fragmentation and variability in the measures that are being asked of clinicians, that again translates into fragmentation variability in their efforts within their practice to improve care for their patients because one payer might be asking them to focus on A1C control greater than 9 and CMS may be asking them to do something different. I think part of it is it makes their improvement efforts a lot more challenging and it increases the burden.
And so, I think this was an effort to try to get harmonization, help reduce the burden and focus on improving efforts. I do want to clarify that our core measures were focused on ambulatory care measurement.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More